Industry news that matters to you.  Learn more

Pacific Biomarkers Awarded $244K Under Health Care Reform Program

Pacific Biomarkers, Inc. a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, reported that it received an award of approximately $244,000 for its ongoing Organ Injury Biomarker Initiative. These funds will reimburse the company for prior and future expenditures through fiscal 2011 in this therapeutic area. The Initiative was recognized as a “Qualifying Therapeutic Discovery Project” under a program created by Congress on May 21, 2010 under the Patient Protection and Affordable Care Act of 2010, the major United States federal health care reform legislation enacted earlier this year.

Novartis Pharmaceuticals Partners with Orasi Medical

Orasi Medical, today announced that it has entered an agreement with Novartis Pharmaceuticals Corporation (Novartis) to develop a novel central nervous system (CNS) biomarker.